8-8890462-T-C
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_004225.3(MFHAS1):c.2597A>G(p.Asn866Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000154 in 1,613,852 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_004225.3 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MFHAS1 | NM_004225.3 | c.2597A>G | p.Asn866Ser | missense_variant | Exon 1 of 3 | ENST00000276282.7 | NP_004216.2 | |
MFHAS1 | XM_047422419.1 | c.2597A>G | p.Asn866Ser | missense_variant | Exon 1 of 3 | XP_047278375.1 | ||
MFHAS1 | XM_011543852.4 | c.2597A>G | p.Asn866Ser | missense_variant | Exon 1 of 2 | XP_011542154.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000920 AC: 14AN: 152238Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000318 AC: 8AN: 251280 AF XY: 0.0000147 show subpopulations
GnomAD4 exome AF: 0.000161 AC: 235AN: 1461614Hom.: 0 Cov.: 80 AF XY: 0.000154 AC XY: 112AN XY: 727116 show subpopulations
GnomAD4 genome AF: 0.0000920 AC: 14AN: 152238Hom.: 0 Cov.: 33 AF XY: 0.000108 AC XY: 8AN XY: 74372 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.2597A>G (p.N866S) alteration is located in exon 1 (coding exon 1) of the MFHAS1 gene. This alteration results from a A to G substitution at nucleotide position 2597, causing the asparagine (N) at amino acid position 866 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at